Importance Despite the potential importance of understanding excess mortality among
people with mental disorders, no comprehensive meta-analyses have been conducted …

Schizophrenia is a life-shortening disease and life expectancy in patients may be 15–20
years shorter than in the general population, with increasing longevity gap over time …

BackgroundMortality has been suggested to be increased in autism spectrum disorder
(ASD). AimsTo examine both all-cause and cause-specific mortality in ASD, as well as …

This new edition of Health at a Glance presents the most recent comparable data on the
performance of health systems in OECD countries. Where possible, it also reports data for …

Importance Premature mortality has been observed among people with mental disorders.
Comorbid general medical conditions contribute substantially to this reduction in life …

The lives of persons living with mental illness are affected by psychological, biological,
social, economic, and environmental factors over the life course. It is therefore unlikely that …

Objective Schizophrenia is highly comorbid with substance use disorders (SUD) but large
epidemiological cohorts exploring the prevalence and prognostic significance of SUD are …

The statistical data for Israel are supplied by and under the responsibility of the relevant
Israeli authorities. The use of such data by the OECD is without prejudice to the status of the …

Individuals with schizophrenia or substance use disorder have a substantially increased
mortality compared to the general population. Despite a high and probably increasing …

Objective To quantify the extent of 'avoidable mortality'in those with schizophrenia or bipolar
disorder and to quantify the effect a reduction in these might have on the mortality gap …